Streetbeat News

Stock Prices

BDRX

Biodexa Pharmaceuticals PLC (NASDAQ:BDRX) has regained compliance with Nasdaq's minimum bid price requirement. The company received a notification from Nasdaq on July 20, 2023, confirming that it has cured the previously disclosed bid price deficiency.

Portfolio Pulse from Charles Gross

July 24, 2023 | 11:33 am

BGS

TSN

WBA

The most accurate Wall Street analysts have recommended holding three high-dividend yield stocks in the consumer staples sector: Tyson Foods, Inc. (TSN), Walgreens Boots Alliance, Inc. (WBA), and B&G Foods, Inc. (BGS). Recent news for these companies includes Tyson Foods' plan to cut corporate jobs and senior leadership positions, Walgreens Boots Alliance's lowered FY23 guidance, and B&G Foods' upbeat Q1 earnings.

Portfolio Pulse from Lisa Levin

July 24, 2023 | 11:31 am

FXI

SPY

Beijing has reportedly asked law firms to moderate the language used to describe China-related business risks in the IPO prospectuses of Chinese companies, according to Reuters. This move could potentially impact the perception of risk associated with investing in Chinese companies listed in the US.

Portfolio Pulse from Charles Gross

July 24, 2023 | 11:19 am

ZION

JP Morgan analyst Steven Alexopoulos has downgraded Zions Bancorp (NASDAQ:ZION) from Overweight to Neutral.

Portfolio Pulse from richadhand@benzinga.com

July 24, 2023 | 11:18 am

DEN

Stifel analyst Nate Pendleton has downgraded Denbury (NYSE:DEN) from Buy to Hold and lowered the price target from $140 to $86.

Portfolio Pulse from richadhand@benzinga.com

July 24, 2023 | 11:16 am

DPZ

Domino's Pizza Inc (NYSE:DPZ) reported a Q2 FY23 sales decline of 3.8% YoY to $1.02 billion, missing the analyst consensus of $1.07 billion. The decrease was due to lower supply chain revenues and order volumes. However, global retail sales increased 5.8% excluding foreign currency impact. The company also reported global net store growth of 197 stores and an EPS of $3.08, beating the analyst consensus of $3.05. The company's Board declared a $1.21 per share quarterly dividend. DPZ shares are trading lower by 4.52% at $368.00 in premarket.

Portfolio Pulse from Shivani Kumaresan

July 24, 2023 | 11:14 am

EFX

B of A Securities analyst David Ridley-Lane has downgraded Equifax (NYSE:EFX) from Neutral to Underperform and set a price target of $195.

Portfolio Pulse from richadhand@benzinga.com

July 24, 2023 | 11:12 am

BMY

IMTX

Bristol Myers Squibb has invested $35 million in Immatics, purchasing approximately 2.4 million shares at $14.461 per share.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 11:09 am

LRCX

Stifel analyst Brian Chin has upgraded Lam Research (NASDAQ:LRCX) from Hold to Buy and raised the price target from $505 to $725.

Portfolio Pulse from richadhand@benzinga.com

July 24, 2023 | 11:09 am

QNCX

Quince Therapeutics, Inc. (NASDAQ:QNCX) has announced plans to acquire EryDel SpA, a late-stage biotech company. The deal involves a stock-for-stock upfront exchange and potential downstream milestone cash payments totaling up to $485 million. Upon completion, EryDel stockholders will own up to 16.7% of the combined company. The transaction will also include the assumption of EryDel's $13 million European Investment Bank loan.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2023 | 11:05 am